REQUEST A DEMO
Total
USD $0.00
Search more companies

Reyon Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Reyon Pharmaceutical Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

REYON Pharmaceutical Co., Ltd is a pharmaceutical company specializing in manufacturing tablets, capsules, and injections, and supplying APIs to pharmaceutical companies in Korea and overseas. They have a finished product production line designed for flexible production under GMP regulations and are recognized for their know-how in synthesis and fermentation technology. REYON Pharmaceutical is also involved in joint pipeline development and CDMO business with various biopharmaceutical companies. They have expanded their biopharmaceutical business through joint development of NK cell therapy and have secured production and supply rights for raw materials and finished products worldwide through joint development agreements. The company has a portfolio of more than 40 APIs and exports finished products to various countries.

Headquarters
38-6 Dongbinggo-Dong, Yongsan-Gu
Seoul; Seoul; Postal Code: 100-833

Contact Details: Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.

Website: http://reyonpharm.co.kr

Basic Information
Total Employees:
Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
November 25, 1964
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
41.36%
Purchase this report to view the information.
10.4%
Purchase this report to view the information.
7.75%
Purchase this report to view the information.
6.26%
Purchase this report to view the information.
3.88%
Subsidiaries
리온즈신약연구소(주)
브라만투자조합1호
아르케인베스트먼트(주)
Company Performance
Financial values in the chart are available after Reyon Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-0.04%
Total operating revenue
-2.43%
Operating profit (EBIT)
-68.6%
EBITDA
-60.2%
Net Profit (Loss) for the Period
-83.75%
Total assets
3.01%
Total equity
-0.34%
Operating Profit Margin (ROS)
-3.93%
Net Profit Margin
-4.54%
Return on Equity (ROE)
-0.68%
Debt to Equity Ratio
6.34%
Quick Ratio
-1.1%
Cash Ratio
-0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?